In order to gain potential insights into the detrimental effect of the combination of both, the presence of harbouring CHIP mutations and LOY ≥17%, on prognosis in patients with heart failure, a paired analysis of LOY and Y cells in patients with and without DNMT3A mutations was performed. This evidence concerns the gene DNMT3A and heart failure.